Literature DB >> 10516802

Memory deficits in patients with schizophrenia: preliminary data from the Wechsler Memory Scale-Third Edition support earlier findings.

K A Hawkins1.   

Abstract

OBJECTIVE: To determine whether memory data presented for a schizophrenia sample in the Technical Manual of the Wechsler Memory Scale-Third Edition support trends identified in a previously published review of studies employing an earlier version of the instrument, the Wechsler Memory Scale-Revised.
DESIGN: Archival: reformulation of published data. PATIENTS: Patients with schizophrenia, Alzheimer's disease, Korsakoff's syndrome or traumatic brain injury (TBI) for whom intelligence and memory data were reported in the Technical Manual of the Wechsler Adult Intelligence Scale-Third Edition Wechsler Memory Scale-Third Edition (WAIS-III WMS-III). OUTCOME MEASURES: Mean Full Scale, Verbal, and Performance Intelligence Quotients of the WAIS-III and mean WMS-III Immediate and General Memory Indexes. Single-trial learning and learning slope data were also culled from the WAIS-III WMS-III Technical Manual.
RESULTS: Memory indexes for patients with Alzheimer's disease or Korsakoff's syndrome were substantially lower than those for patients with schizophrenia or TBI. In tests of learning processes, patients with schizophrenia had an inferior ability to repeat material presented just once, in comparison with the standardization sample. However, they did relatively better with repeated presentations than patients with Alzheimer's disease or Korsakoff's syndrome. The learning slope for patients with schizophrenia demonstrated an ability to absorb and consolidate increasing amounts of material with repeated exposure that is inconsistent with pronounced memory impairment.
CONCLUSIONS: Although patients with schizophrenia exhibit new learning deficiencies, their memory capabilities are not substantially weaker than their general intellectual abilities, and do not approach the memory impairment exhibited by patients with Alzheimer's disease or Korsakoff's syndrome.

Entities:  

Mesh:

Year:  1999        PMID: 10516802      PMCID: PMC1189037     

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN: 1180-4882            Impact factor:   6.186


  6 in total

Review 1.  Contributions of clinical neuropsychology to the study of schizophrenia.

Authors:  S Levin; D Yurgelun-Todd; S Craft
Journal:  J Abnorm Psychol       Date:  1989-11

2.  Cognition, negative symptoms, and diagnosis: a comparison of schizophrenic, bipolar, and control samples.

Authors:  K A Hawkins; R E Hoffman; D M Quinlan; J Rakfeldt; N M Docherty; W H Sledge
Journal:  J Neuropsychiatry Clin Neurosci       Date:  1997       Impact factor: 2.198

Review 3.  Memory deficits in schizophrenia: inadequate assimilation or true amnesia? Findings from the Wechsler Memory Scale--revised.

Authors:  K A Hawkins; T E Sullivan; E J Choi
Journal:  J Psychiatry Neurosci       Date:  1997-05       Impact factor: 6.186

Review 4.  Relationship of prefrontal and temporal lobe MRI measures to neuropsychological performance in chronic schizophrenia.

Authors:  L J Seidman; D Yurgelun-Todd; W S Kremen; B T Woods; J M Goldstein; S V Faraone; M T Tsuang
Journal:  Biol Psychiatry       Date:  1994-02-15       Impact factor: 13.382

5.  Neuropsychological correlates of MRI temporal lobe abnormalities in schizophrenia.

Authors:  P G Nestor; M E Shenton; R W McCarley; J Haimson; R S Smith; B O'Donnell; M Kimble; R Kikinis; F A Jolesz
Journal:  Am J Psychiatry       Date:  1993-12       Impact factor: 18.112

6.  Neuropsychological deficits in neuroleptic naive patients with first-episode schizophrenia.

Authors:  A J Saykin; D L Shtasel; R E Gur; D B Kester; L H Mozley; P Stafiniak; R C Gur
Journal:  Arch Gen Psychiatry       Date:  1994-02
  6 in total
  7 in total

1.  Medial temporal lobe structure and cognition in individuals with schizophrenia and in their non-psychotic siblings.

Authors:  Meghana S Karnik-Henry; Lei Wang; Deanna M Barch; Michael P Harms; Carolina Campanella; John G Csernansky
Journal:  Schizophr Res       Date:  2012-04-26       Impact factor: 4.939

2.  Associations of SNAP-25 polymorphisms with cognitive dysfunctions in Caucasian patients with schizophrenia during a brief trail of treatment with atypical antipsychotics.

Authors:  Ilja Spellmann; Norbert Müller; Richard Musil; Peter Zill; Anette Douhet; Sandra Dehning; Anja Cerovecki; Brigitta Bondy; Hans-Jürgen Möller; Michael Riedel
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-03-17       Impact factor: 5.270

3.  Efficacy of olanzapine versus quetiapine on cognitive dysfunctions in patients with an acute episode of schizophrenia.

Authors:  Michael Riedel; Norbert Müller; Ilja Spellmann; Rolf R Engel; Richard Musil; Rosamaria Valdevit; Sandra Dehning; Anette Douhet; Anja Cerovecki; Martin Strassnig; Hans-Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2007-10       Impact factor: 5.270

4.  Effects of risperidone and quetiapine on cognition in patients with schizophrenia and predominantly negative symptoms.

Authors:  Michael Riedel; Ilja Spellmann; Martin Strassnig; Anette Douhet; Sandra Dehning; Markus Opgen-Rhein; Rosamaria Valdevit; Rolf R Engel; Nikolaus Kleindienst; Norbert Müller; Hans-Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2007-07-14       Impact factor: 5.270

5.  Neuropsychological testing and structural magnetic resonance imaging as diagnostic biomarkers early in the course of schizophrenia and related psychoses.

Authors:  Elissaios Karageorgiou; S Charles Schulz; Randy L Gollub; Nancy C Andreasen; Beng-Choon Ho; John Lauriello; Vince D Calhoun; H Jeremy Bockholt; Scott R Sponheim; Apostolos P Georgopoulos
Journal:  Neuroinformatics       Date:  2011-12

6.  Different characteristics of cognitive impairment in elderly schizophrenia and Alzheimer's disease in the mild cognitive impairment stage.

Authors:  Hiroaki Kazui; Tetsuhiko Yoshida; Masahiko Takaya; Hiromichi Sugiyama; Daisuke Yamamoto; Yumiko Kito; Tamiki Wada; Keiko Nomura; Yuka Yasuda; Hidenaga Yamamori; Kazutaka Ohi; Motoyuki Fukumoto; Naomi Iike; Masao Iwase; Takashi Morihara; Shinji Tagami; Eku Shimosegawa; Jun Hatazawa; Yoshiyuki Ikeda; Eiichi Uchida; Toshihisa Tanaka; Takashi Kudo; Ryota Hashimoto; Masatoshi Takeda
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2011-01-06

7.  Effects of Amisulpride Adjunctive Therapy on Working Memory and Brain Metabolism in the Frontal Cortex of Patients with Schizophrenia: A Preliminary Positron Emission Tomography/Computerized Tomography Investigation.

Authors:  Jeong Ha Park; Ji Son Hong; Sun Mi Kim; Kyung Joon Min; Un Sun Chung; Doug Hyun Han
Journal:  Clin Psychopharmacol Neurosci       Date:  2019-05-31       Impact factor: 2.582

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.